192 related articles for article (PubMed ID: 19528278)
1. New semiphysiological absorption model to assess the pharmacodynamic profile of cefuroxime axetil using nonparametric and parametric population pharmacokinetics.
Bulitta JB; Landersdorfer CB; Kinzig M; Holzgrabe U; Sorgel F
Antimicrob Agents Chemother; 2009 Aug; 53(8):3462-71. PubMed ID: 19528278
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic comparison and pharmacodynamic breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteers.
Bulitta JB; Landersdorfer CB; Hüttner SJ; Drusano GL; Kinzig M; Holzgrabe U; Stephan U; Sörgel F
Antimicrob Agents Chemother; 2010 Mar; 54(3):1275-82. PubMed ID: 20065059
[TBL] [Abstract][Full Text] [Related]
3. Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat uncomplicated acute pyelonephritis after switching from intravenous therapy? A pharmacokinetic/pharmacodynamic perspective.
Rodríguez-Gascón A; Aguirre-Quiñonero A; Canut-Blasco A
Enferm Infecc Microbiol Clin (Engl Ed); 2020; 38(7):306-311. PubMed ID: 32085928
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.
James NC; Donn KH; Collins JJ; Davis IM; Lloyd TL; Hart RW; Powell JR
Antimicrob Agents Chemother; 1991 Sep; 35(9):1860-3. PubMed ID: 1952858
[TBL] [Abstract][Full Text] [Related]
5. Comparable population pharmacokinetics and pharmacodynamic breakpoints of cefpirome in cystic fibrosis patients and healthy volunteers.
Bulitta JB; Kinzig M; Landersdorfer CB; Holzgrabe U; Stephan U; Sörgel F
Antimicrob Agents Chemother; 2011 Jun; 55(6):2927-36. PubMed ID: 21402834
[TBL] [Abstract][Full Text] [Related]
6. Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects.
Lodise TP; Pypstra R; Kahn JB; Murthy BP; Kimko HC; Bush K; Noel GJ; Drusano GL
Antimicrob Agents Chemother; 2007 Jul; 51(7):2378-87. PubMed ID: 17387149
[TBL] [Abstract][Full Text] [Related]
7. Effect of food on the pharmacokinetics of oral cefuroxime axetil in dogs.
Albarellos GA; Passini SM; Lupi MP; Aramayona S; Lorenzini PM; Montoya L; Landoni MF
J Vet Pharmacol Ther; 2020 May; 43(3):297-302. PubMed ID: 32157713
[TBL] [Abstract][Full Text] [Related]
8. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Perry CM; Brogden RN
Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
[TBL] [Abstract][Full Text] [Related]
9. How can we predict bacterial eradication?
Jacobs MR
Int J Infect Dis; 2003 Mar; 7 Suppl 1():S13-20. PubMed ID: 12839703
[TBL] [Abstract][Full Text] [Related]
10. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
11. Cefuroxime pharmacokinetics and pharmacodynamics for intravenous dosage regimens with 750 mg or 1500 mg doses in healthy young volunteers.
Thønnings S; Jensen KS; Nielsen NB; Skjønnemand M; Hansen DS; Lange KHW; Frimodt-Møller N
J Med Microbiol; 2020 Mar; 69(3):387-395. PubMed ID: 31958049
[No Abstract] [Full Text] [Related]
12. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.
Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358296
[TBL] [Abstract][Full Text] [Related]
13. [Role of cefuroxime-axetil in the treatment of respiratory tract infections. Bacteriological and pharmacological data].
Bergogne-Berezin E; Vallée E; Muller-Serieys C
Therapie; 1991; 46(4):333-7. PubMed ID: 1948811
[TBL] [Abstract][Full Text] [Related]
14. Measuring antibiotic levels in otitis media.
Thoroddsen E
Ear Nose Throat J; 1998 Jun; 77(6 Suppl):13-5. PubMed ID: 9674329
[TBL] [Abstract][Full Text] [Related]
15. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
Peric M; Browne FA; Jacobs MR; Appelbaum PC
Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cefuroxime axetil suspension in infants and children.
Powell DA; James NC; Ossi MJ; Nahata MC; Donn KH
Antimicrob Agents Chemother; 1991 Oct; 35(10):2042-5. PubMed ID: 1759825
[TBL] [Abstract][Full Text] [Related]
17. Killing kinetics of cefuroxime axetil against Haemophilus influenzae in an in-vitro model simulating serum concentration profiles after oral administration.
Bingen E; Lambert-Zechovsky N; Doit C; Duvignaud P; Georges D; Mariani-Kurkdjian P
J Antimicrob Chemother; 1991 Oct; 28(4):533-6. PubMed ID: 1761448
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin.
Landersdorfer CB; Kirkpatrick CM; Kinzig-Schippers M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
Antimicrob Agents Chemother; 2007 Sep; 51(9):3290-7. PubMed ID: 17576847
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime.
Ruiz-Carretero P; Merino-Sanjuán M; Nácher A; Casabó VG
Eur J Pharm Sci; 2004 Feb; 21(2-3):217-23. PubMed ID: 14757493
[TBL] [Abstract][Full Text] [Related]
20. Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine.
Ibar-Bariain M; Rodríguez-Gascón A; Isla A; Solinís MA; Canut-Blasco A
Rev Esp Quimioter; 2019 Apr; 32(2):121-129. PubMed ID: 30727714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]